TurboCHO™ High Throughput Platform (Upgraded to 2.0 version starting at 5BDs)
From Gene Synthesis to Delivery as Fast as 5 Business Days
Receive your quote directly from the manufacturer.
High throughput (HT) gene to antibody production offers the most cost-effective option for small-scale recombinant antibodies. Empowered by GenScript’s high throughput gene synthesis platform and proprietary TurboCHO™ transient expression technology, small-scale projects, starting from customer-supplied sequences to purified products, can be completed in as short as 5 business days, helping to accelerate therapeutic development and commercialization globally!
Key features:
1. As fast as 5 business days
2. A large capacity of 1,000+ targets/day
3. Multiple isotypes, IgGs, Fab, scFv, VHH, bi-specific antibodies, and more
4. Flexible quantities (i.e., from ug to mg)
Relevant applications:
High throughput screening at the early stage of antibody drug discovery
